(3S,5R)-5-methylpiperidin-3-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (3S,5R)-5-methylpiperidin-3-amine
• 英文别名: (3S,5R)-5-Methylpiperidin-3-amine
• 化学式: C₆H₁₄N₂
• 分子量: 114.191
• InChiKey: PQOHPULQDOKUOG-RITPCOANSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (3S,5R)-5-methylpiperidin-3-amine 、 3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-6,7-difluoro-1H-indole 在 N,N-二异丙基乙胺 、 盐酸 作用下， 以 N-甲基吡咯烷酮 、 甲醇 为溶剂， 以44.53 %的产率得到4-(6,7-difluoro-1H-indol-3-yl)-N-((3S,5R)-5-methylpiperidin-3-yl)-5-(trifluoromethyl)pyrimidin-2-amine hydrochloride
  参考文献：
  名称：

  [EN] A CYCLIN-DEPENDENT KINASE INHIBITOR
  [FR] INHIBITEUR DE KINASE DÉPENDANTE DES CYCLINES

  摘要：

  Provided herein are a series of compounds as potent inhibitors of cyclin-dependent kinase (CDK), or pharmaceutically acceptable salts thereof. Corresponding compositions are also provided.

  公开号：

  WO2023040998A1

文献信息

• [EN] HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS<br/>[FR] COMPOSÉS SPIRO HÉTÉROCYCLIQUES CONSTITUANT DES INHIBITEURS DU RÉCEPTEUR DE L'AM2
  申请人：UNIV SHEFFIELD

  公开号：WO2020099882A1

  公开（公告）日：2020-05-22

  Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein HET, R1, R2, R3, R4, R5, L, L1, X1, X2, X3 and q are as defined herein. The compounds are inhibitors of adrenomedullin receptor subtype 2 (AM2). Also disclosed are the compounds for use in the treatment of diseases modulated AM2, including proliferative diseases such as cancer; pharmaceutical compositions comprising the compounds; methods for preparing the compounds; and intermediates useful in the preparation of the compounds.

  揭示了式(I)的化合物及其药学上可接受的盐：其中HET、R1、R2、R3、R4、R5、L、L1、X1、X2、X3和q如本文所定义。这些化合物是肾上腺髓质素受体亚型2（AM2）的抑制剂。还揭示了这些化合物用于治疗调节AM2的疾病，包括增殖性疾病如癌症；包含这些化合物的药物组合物；制备这些化合物的方法；以及制备这些化合物的有用中间体。
• [EN] BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS<br/>[FR] COMPOSÉS DE CARBOXAMIDE AROMATIQUE BICYCLIQUE UTILES COMME INHIBITEURS DE PIM KINASE
  申请人：INCYTE CORP

  公开号：WO2014110574A1

  公开（公告）日：2014-07-17

  The present disclosure describes bicyclic aromatic carboxamide derivatives of formula (I), as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
• [EN] THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS<br/>[FR] COMPOSÉS DE THIAZOLECARBOXAMIDE ET DE PYRIDINECARBOXAMIDE UTILES COMME INHIBITEURS DE KINASES PIM
  申请人：INCYTE CORP

  公开号：WO2014113388A1

  公开（公告）日：2014-07-24

  The present disclosure describes thiazole and pyridine carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof, wherein: X is C or N; A, B and D are rings; the bond— represents a normalized bond within the aromatic ring containing both an N and X, which formally is represented by a C=C bond when X is C and a single bond when X is N; ring A is of the formula (A-l) or (A-2): wherein El and E2 are rings; their compositions and methods of use. The compounds inhibit the activity of the Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
• [EN] A CYCLIN-DEPENDENT KINASE INHIBITOR<br/>[FR] INHIBITEUR DE KINASE DÉPENDANTE DES CYCLINES
  申请人：[en]TAIZHOU EOC PHARMA CO., LTD.

  公开号：WO2023040998A1

  公开（公告）日：2023-03-23

  Provided herein are a series of compounds as potent inhibitors of cyclin-dependent kinase (CDK), or pharmaceutically acceptable salts thereof. Corresponding compositions are also provided.